13F Data
Security · CUSIP 02043QAB3

ALNYLAM PHARMACEUTICALS INC

NOTE 1.000% 9/1 · institutional ownership from 13F filings
13F holders
5
Shares held
594.8K
Value held
$715.3K
New / sold out
0 / 4
Added / reduced
0 / 1
net -13.9M shares

13F holders by quarter

Q3 2023: 8Q4 2023: 11Q1 2024: 9Q2 2024: 11Q3 2024: 9Q4 2024: 10Q1 2025: 8Q2 2025: 7Q3 2025: 7Q4 2025: 11Q1 2026: 9Q2 2026: 5Q3 2026: 2
Q3 2023Q3 2026

Net shares bought by existing holders

Q3 2023: 24.1MQ4 2023: 4.2MQ1 2024: 27.6MQ2 2024: -34.6MQ3 2024: -7.5MQ4 2024: 6.3MQ1 2025: -5.9MQ2 2025: 2.7MQ3 2025: -4.8MQ4 2025: 8.9MQ1 2026: 1.3MQ2 2026: -13.9MQ3 2026: -1.0K
Q3 2023Q3 2026

Top holders · Q2 2026

ManagerSharesValue% of portfolio
SEI INVESTMENTS CO251,000$301.8K0.00%
Bank of New York Mellon Corp215,000$258.7K0.00%
OPPENHEIMER ASSET MANAGEMENT INC.80,000$96.2K0.00%
BOUSSARD & GAVAUDAN GESTION SAS24,763$29.8K0.00%
STEPHENS INC /AR/24,000$28.9K0.00%

Biggest buyers

Nothing to show.

Biggest sellers

ManagerChangeShares changeChange %
BNP PARIBAS ASSET MANAGEMENT Holding S.A.Sold out-9,750,000-100.0%
SSI INVESTMENT MANAGEMENT LLCSold out-4,098,000-100.0%
MML INVESTORS SERVICES, LLCSold out-10,000-100.0%
LOOMIS SAYLES & CO L PSold out-4,860-100.0%
OPPENHEIMER ASSET MANAGEMENT INC.Reduced-1,000-1.2%